$41.70
+0.0100 (+0.0240%)
At Close: Jun 03, 2026
XOMA to Present at the 42nd Annual Cowen Health Care Conference
12:30pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of impro
XOMA to Present at the 42nd Annual Cowen Health Care Conference
07:30am, Tuesday, 01'st Mar 2022
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvi
XOMA (XOMA) Investor Presentation - Slideshow
05:30pm, Sunday, 27'th Feb 2022 Seeking AlphaXOMA to Present at Aegis Capital Corp Investor Conference
12:30pm, Thursday, 17'th Feb 2022 GlobeNewswire Inc.
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improv
XOMA to Present at Aegis Capital Corp Investor Conference
07:30am, Thursday, 17'th Feb 2022
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvin
XOMA Declares Quarterly Preferred Stock Dividends
12:30pm, Thursday, 23'rd Dec 2021 GlobeNewswire Inc.
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash divid
XOMA Declares Quarterly Preferred Stock Dividends
12:30pm, Thursday, 23'rd Dec 2021 GlobeNewswire
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (XOMA or the Company) today announced its Board of Directors has authorized the following cash dividends to holders of XOMAs Series A and Series B Cumulative Preferred Stock:
XOMA to Present at Upcoming Investor Conferences
12:30pm, Tuesday, 21'st Dec 2021 GlobeNewswire Inc.
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improv
XOMA to Present at Upcoming Investor Conferences
07:30am, Tuesday, 21'st Dec 2021
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improvin
XOMA Announces Evolution of Company Leadership and Succession Planning
12:30pm, Thursday, 16'th Dec 2021 GlobeNewswire Inc.
Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director
XOMA Announces Evolution of Company Leadership and Succession Planning
12:30pm, Thursday, 16'th Dec 2021 Intrado Digital Media
Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director
XOMA Co. (NASDAQ:XOMA) Stock Position Raised by State Street Corp
11:50am, Tuesday, 30'th Nov 2021 Transcript Daily
State Street Corp lifted its stake in XOMA Co. (NASDAQ:XOMA) by 13.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 120,424 shares of the biotechnology companys stock after acquiring an additional 14,475 shares during the period. State Street Corp owned 1.06% of XOMA worth $4,094,000 []
Botulinum Market Expansion Projected to Gain an Uptick During 2021-2027 Covid-19 Analysis | XOMA, AlphaVax
04:53pm, Monday, 22'nd Nov 2021 OpenPR
Another exploration Titled "Worldwide Botulinum 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central point, for
Sign In
Buy XOMA